• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

壳聚糖气雾剂吸入可减轻脂多糖诱导的大鼠肺纤维化。

Chitosan aerosol inhalation alleviates lipopolysaccharide- induced pulmonary fibrosis in rats.

作者信息

Zhou Lu-Lu, He Xing-Ying, Xu Feng-Ying, Du Bo-Xiang, Zou Zui, Shi Xue-Yin

机构信息

Department of Anesthesiology, Changzheng Hospital, Second Military Medical University, Shanghai, People's Republic of China.

出版信息

Exp Lung Res. 2014 Nov;40(9):467-73. doi: 10.3109/01902148.2014.948231.

DOI:10.3109/01902148.2014.948231
PMID:25322333
Abstract

PURPOSE

Pulmonary fibrosis (PF) is an insidiously progressive scarring disorder of the alveoli and is associated with high mortality. Currently, therapies available are associated with restricted efficacy and side effects. This study aimed to investigate the effect of chitosan aerosol inhalation on lipopolysaccharide (LPS)-induced pulmonary remodeling and fibrosis in rats.

METHODS

A rat model of PF was established by intratracheal injection of LPS (5 mg/kg). Chitosan was nebulized to rats from day 4 to 28 after LPS injection. We analyzed the effect of chitosan on LPS-induced pulmonary remodeling and fibrosis by hematoxylin-eosin staining (HE), Masson staining, and the determination of the hydroxyproline content. The expression intensities of matrix metalloproteinase-3 (MMP-3) and tissue inhibitor of metalloproteinase-1 (TIMP-1) were analyzed by western blots.

RESULTS

Histological assessments showed that chitosan aerosol inhalation attenuated the fibrotic changes in LPS-induced PF in rats. Compared with the LPS group, the fibrosis parameters were significantly improved in the LPS + chitosan group (LCh group), although not as good as those of the control group. The expressions of MMP-3 and TIMP-1 in the LCh group were markedly less than that of the LPS group on the 28th day.

CONCLUSIONS

Our findings show that chitosan aerosol inhalation inhibits the expression of MMP-3 and TIMP-1, and ameliorates LPS-induced pulmonary remodeling and fibrosis in rats.

摘要

目的

肺纤维化(PF)是一种肺泡的隐匿性进行性瘢痕形成疾病,且与高死亡率相关。目前,可用的治疗方法疗效有限且伴有副作用。本研究旨在探讨壳聚糖气雾剂吸入对脂多糖(LPS)诱导的大鼠肺重塑和纤维化的影响。

方法

通过气管内注射LPS(5 mg/kg)建立PF大鼠模型。在LPS注射后第4天至第28天对大鼠进行壳聚糖雾化。我们通过苏木精-伊红染色(HE)、Masson染色以及羟脯氨酸含量测定来分析壳聚糖对LPS诱导的肺重塑和纤维化的影响。通过蛋白质印迹法分析基质金属蛋白酶-3(MMP-3)和金属蛋白酶组织抑制剂-1(TIMP-1)的表达强度。

结果

组织学评估显示,壳聚糖气雾剂吸入减轻了LPS诱导的大鼠PF的纤维化改变。与LPS组相比,LPS +壳聚糖组(LCh组)的纤维化参数显著改善,尽管不如对照组。在第28天,LCh组中MMP-3和TIMP-1的表达明显低于LPS组。

结论

我们的研究结果表明,壳聚糖气雾剂吸入可抑制MMP-3和TIMP-1的表达,并改善LPS诱导的大鼠肺重塑和纤维化。

相似文献

1
Chitosan aerosol inhalation alleviates lipopolysaccharide- induced pulmonary fibrosis in rats.壳聚糖气雾剂吸入可减轻脂多糖诱导的大鼠肺纤维化。
Exp Lung Res. 2014 Nov;40(9):467-73. doi: 10.3109/01902148.2014.948231.
2
Effects of Chinese herbal medicine Shenlong Decoction on mRNA expressions of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 in lung tissue of rats with pulmonary fibrosis induced by bleomycin.中药神龙汤对博莱霉素诱导的肺纤维化大鼠肺组织基质金属蛋白酶-2及金属蛋白酶组织抑制剂-1 mRNA表达的影响
Zhong Xi Yi Jie He Xue Bao. 2010 Oct;8(10):961-7. doi: 10.3736/jcim20101008.
3
[Feature changes of MMP-2/9 activities and TIMP-1/2 protein expressions during the progression of pulmonary fibrosis in rats].[大鼠肺纤维化进程中MMP-2/9活性及TIMP-1/2蛋白表达的特征性变化]
Zhong Xi Yi Jie He Xue Bao. 2006 Jul;4(4):402-7. doi: 10.3736/jcim20060417.
4
Rapamycin attenuates bleomycin-induced pulmonary fibrosis in rats and the expression of metalloproteinase-9 and tissue inhibitors of metalloproteinase-1 in lung tissue.雷帕霉素可减轻博来霉素诱导的大鼠肺纤维化以及肺组织中金属蛋白酶-9和金属蛋白酶组织抑制剂-1的表达。
Chin Med J (Engl). 2014;127(7):1304-9.
5
Low dose pirfenidone suppresses transforming growth factor beta-1 and tissue inhibitor of metalloproteinase-1, and protects rats from lung fibrosis induced by bleomycina.低剂量吡非尼酮可抑制转化生长因子β-1和金属蛋白酶组织抑制剂-1,并保护大鼠免受博莱霉素诱导的肺纤维化。
Chin Med Sci J. 2006 Sep;21(3):145-51.
6
Losartan attenuates paraquat-induced pulmonary fibrosis in rats.氯沙坦减轻百草枯诱导的大鼠肺纤维化。
Hum Exp Toxicol. 2015 May;34(5):497-505. doi: 10.1177/0960327114543840. Epub 2014 Sep 17.
7
Effects of hydroxycamptothecin on the expression of matrix metalloproteinase-1 (MMP-1), tissue inhibitor of MMP-1, and type I collagen in rats with pulmonary fibrosis.羟基喜树碱对肺纤维化大鼠基质金属蛋白酶-1(MMP-1)、MMP-1组织抑制剂及Ⅰ型胶原表达的影响
Genet Mol Res. 2015 May 4;14(2):4625-32. doi: 10.4238/2015.May.4.21.
8
Time course of matrix metalloproteases and tissue inhibitors in bleomycin-induced pulmonary fibrosis.博来霉素诱导的肺纤维化中基质金属蛋白酶和组织抑制剂的时间进程。
Eur J Histochem. 2006 Oct-Dec;50(4):317-25.
9
Total glucosides of Danggui Buxue Tang attenuates bleomycin-induced pulmonary fibrosis via inhibition of extracellular matrix remodelling.当归补血汤总苷通过抑制细胞外基质重塑减轻博来霉素诱导的肺纤维化。
J Pharm Pharmacol. 2012 Jun;64(6):811-20. doi: 10.1111/j.2042-7158.2012.01490.x. Epub 2012 Apr 5.
10
[Effects of Fuzheng Huayu recipe on MMP-2 activity and type IV collagen expression at fibrotic lung].扶正化瘀方对肺纤维化中基质金属蛋白酶-2活性及IV型胶原表达的影响
Zhongguo Zhong Yao Za Zhi. 2007 May;32(9):835-9.

引用本文的文献

1
In vitro atomization analysis and evaluation of inhalable sodium sivelestat formulations.体外雾化分析与可吸入性盐酸西维来司他制剂的评价。
PLoS One. 2024 Sep 20;19(9):e0309721. doi: 10.1371/journal.pone.0309721. eCollection 2024.
2
Insights into the Role of Bioactive Food Ingredients and the Microbiome in Idiopathic Pulmonary Fibrosis.生物活性食物成分和微生物组在特发性肺纤维化中的作用研究进展。
Int J Mol Sci. 2020 Aug 22;21(17):6051. doi: 10.3390/ijms21176051.
3
Oral Administration of Chitosan Attenuates Bleomycin-induced Pulmonary Fibrosis in Rats.
口服壳聚糖可减轻博来霉素诱导的大鼠肺纤维化。
In Vivo. 2019 Sep-Oct;33(5):1455-1461. doi: 10.21873/invivo.11624.
4
Combination therapy of chitosan, gynostemma, and motherwort alleviates the progression of experimental rat chronic renal failure by inhibiting STAT1 activation.壳聚糖、绞股蓝和益母草联合治疗通过抑制STAT1激活减轻实验性大鼠慢性肾衰竭的进展。
Oncotarget. 2018 Jan 10;9(21):15498-15511. doi: 10.18632/oncotarget.24125. eCollection 2018 Mar 20.